[Expression and clinical significance of TGF-beta1 and its signaling pathway proteins in nasopharyngeal carcinoma].
Transforming growth factor beta (TGF-beta) has various biological functions, and plays important roles in cell proliferation, differentiation and apoptosis. This study was to investigate the expression and clinical significance of TGF-beta1 and its signaling pathway proteins (TGF-beta1 receptors TGFbetaRI and TGFbetaRII, cytoplasmic mediator Smad4) in nasopharyngeal carcinoma (NPC). The expression of TGF-beta1, TGFbetaRI, TGFbetaRII, and Smad4 in 91 specimens of NPC was detected by SP immunohistochemistry. Their correlations to local relapse, distant metastasis and survival rate of the patients were analyzed. The positive rates of TGF-beta1, TGFbetaRI, TGFbetaRII and Smad4 were 69.2%, 73.6%, 62.6% and 72.5% in NPC. The differences in the positive rates of TGF-beta1 (0, 12.7%, 50.8%, and 36.5%) and TGFbetaRII (0, 15.8%, 54.4%, and 29.8%) among stageI, II, III and IV NPC were significant (P<0.05). However, there was no significant difference in the expression of TGFbetaRI and Smad4. The local relapse rate was significantly higher and 5-year overall survival rate was significantly lower in TGF-beta1-positive patients than in TGF-beta1-negative patients (22.2% vs. 3.6%, P<0.05û 63.5% vs. 82.1%, P<0.05). All the 4 proteins had no correlation to the distant metastasis of NPC (P>0.05). Autocrine TGF-beta1 exists in NPC patients, which is correlated to the local relapse and survival.